Acta.2002
Additionally, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity trial demonstrated that semaglutide consistently reduced major cardiovascular event endpoints by approximately 20% compared to placebo over an approximately 3-year follow-up period in patients with overweight or obesity and cardiovascular disease (Table 1), but without diabetes [93]
From a practical standpoint, the most defensible position remains planned exposure avoidance: explicit fertility planning, reliable contraception during treatment, label-informed discontinuation before conception attempts, immediate cessation once pregnancy is recognized, and active metabolic maintenance during the washout period to reduce rebound-related gestational risk (132137)
4.3.1 Adipose tissue-derived inflammatory factors During obesity, as adipose tissue volume increases, localized hypoxia develops
It is essential to discuss all medications, supplements, and herbal products you are taking with your doctor to avoid potential interactions or adverse effects
Ozempic is an injectable medication taken under the skin in the stomach area (abdomen), upper leg (thigh), or upper arm per the instructions of a healthcare provider
.jpg)
